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Abstract
Necrotizing and granulomatous meningoencephalitis are common central nervous system diseases known to affect canines. To date, necrotizing granulomatous meningoencephalitis has
yet to be described in humans. Current studies of presumed pathogenesis and possible treatment options have only been described in canines. This is a case report of a 55-year-old female
patient who was diagnosed with necrotizing granulomatous meningoencepha litis in the setting of new-onset neurological symptoms without any infectious or malignant source.
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Introduction

Chronic necrotizing and granulomatous meningoencephalitis are idiopathic inflammatory diseases that commonly affect the central nervous system of canines, however, have not
been identified in humans yet. These diseases have been associated with specific dog breeds,
causing a progressive fatal disease with consistent neuropathological changes [1]. Canine meningoencephalitis is further classified into necrotizing and granulomatous meningoencephalitis based on pathological findings, yet these subclasses are suspected to share a possibly autoimmune pathogenesis [2]. Although these idiopathic inflammatory central nervous system
diseases have been identified and investigated within the canine species, necrotizing granulomatous meningoencephalitis has not been readily identified and studied in h umans. Here,
we report a case of chronic necrotizing granulomatous meningoencephalitis in an adult female
patient.
Case Report

The patient is a 55-year-old right-handed female with a past medical history of previous
diagnosis of chronic lymphocytic leukemia, and recurrent TB exposure presenting with newonset daily frontal headaches. She originally presented to her primary care physician with intermittent burning left frontal headaches that were worse with exertion and without associated focal neurologic deficit. Initial neurological examination was unremarkable. MRI of the
brain revealed an 11-mm left frontal lobe enhancing lesion with surrounding vasogenic
edema, as well as multiple punctate bilateral cortical/subcortical enhancing lesions (Fig. 1).
Her headaches began to worsen in intensity and frequency and were associated with new onset right facial tingling and intermittent bilateral upper and lower extremity pain. Extensive
infectious, autoimmune, and neoplastic workup was completed and was unremarkable. Malignancy workup included CT of the chest, abdomen, and pelvis, followed by a whole -body
bone scan, PET-CT, and flow cytometry which were all negative for malignancy. A summary of
the infectious and autoimmune workup can be found in Table 1.
The patient was referred to neurosurgery for open brain biopsy targeting the left frontal
enhancing lesion. Postoperative neurologic examination demonstrated a mild expressive
aphasia with word finding difficulties. Neuropathology revealed chronic granulomatous inflammation of the brain and meninges. The granulomas noted within the meninges showed
central necrosis surrounded by a rim of lymphocytes, plasma cells, and epithelioid histiocytes
in addition to eosinophils and giant cells. Marked fibrosis and burnt-out granulomas were
seen within both the meninges and brain tissue with dense perivascular lymphoplasmacytic
infiltrate along with reactive gliosis within the cerebral cortex. These findings were consistent
with chronic necrotizing granulomatous meningoencephalitis. There were no findings on biopsy consistent with mycobacterial infection.
The patient was treated with intravenous 1,000 mg Solumedrol for 3 days followed by a
6-week prednisone taper. Over the next 6 months, the patient remained clinically stable with
mild expressive aphasia. Six months after treatment, she began having staring spells that
started with a strange feeling. No EEG correlate was noted on long-term EEG monitoring; however, she was started on Lamictal for high suspicion of focal seizures, with complete resolution
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of symptoms. She remained clinically and radiographically stable without additional treatment for 4 years until the most recent MRI in 2018 suggesting recurrence (Fig. 2).
Discussion

Chronic necrotizing granulomatous meningoencephalitis, although extensively studied in
canines, has yet to be described in humans. Canines can display a wide variety of clinical symptoms depending on the location of the lesions. Common symptoms of necrotizing meningoencephalitis in canines include seizures, paresis, ataxia, visual defects, lethargy, behavioral
changes, excessive walking in circles, and death [3, 4]. Although necrotizing meningoencephalitis and granulomatous meningoencephalitis can be classified as two distinct processes, the
proportion of inflammatory cells does not differ among them, suggesting that they are a spectrum of the same disease with shared pathogenesis [5]. Pathology of these diseases consist of
necrosis with infiltration of lymphocytes, plasma cells, and histiocytes within the leptomeninges and the cerebral cortex [5]. Granulomatous lesions with epithelioid cells are seen in addition to perivascular cuffs consisting of lymphocytes, plasma cells, and macrophages [5].
Although the pathogenesis remains unclear, research suggests a possible autoimmune
mediated delayed-type hypersensitivity response due to the significant presence of CD3
T-lymphocytes and major histocompatibility complex class II [5, 6]. It is theorized that the
granulomatous nature of the disease further supports an immune mediated etiology. Variants
of meningoencephalitis can be associated with specific canine breeds with a higher predilection for females, although both sexes are affected [7].
Studies have yet to identify a single infectious, environmental, or genetics basis, suggesting that multiple factors play a role in disease pathogenesis [6]. Genetic predisposition has
been identified in certain breeds [1]. Common infectious causes of canine central nervous system disease, such as canine distemper, Cryptococcus neoformans, Ehrlichia canis, Neospora
caninum, Rickettsia rickettsii, and Toxoplasma gondii, have yet to be isolated in canines with
necrotizing granulomatous meningoencephalitis [4]. Mycoplasma canis has been isolated at a
higher frequency from canines with necrotizing granulomatous meningoencephalitis; however, this difference was not found to be statistically significant when compared to controls
[1]. There has yet to be correlation with any viral infections as well, but it remains unclear if
possible past exposure could potentiate these diseases [3].
Overall, definitive diagnosis is made postmortem during autopsy of deceased or euthanized canines. It remains difficult to diagnose canines prior to autopsy but living diagnosis
can be supported by CSF findings that exclude other infectious etiologies. Additionally, MRI or
CT findings consisting of solitary or multiple contrast-enhancing lesions can back up the diagnosis when suspicious for inflammatory meningoencephalitis [7].
There is currently no gold standard treatment for necrotizing granulomatous meningoencephalitis in canines as treatment protocols are largely based on case reports alone and overall it represents a broad spectrum of diseases [6]. The typical treatment for these canines includes immunosuppression with corticosteroids, although neurological symptoms can recur
after treatment [7]. Other secondary immunomodulatory drugs such as cyclosporine, cytosine
arabinoside, leflunomide, lomustine, and mycophenolate mofetil show promising results but
require further evaluation for efficacy [6]. Additionally, use of antiepileptics are suggested in
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canines with seizures [2]. Despite treatment, the prognosis remains poor, yet canines with
focal disease tend to survive longer than those with disseminated disease [6].
After a thorough literature review, this is the first case of human chronic necrotizing granulomatous meningoencephalitis to be reported. The similar pathological findings in canines
with necrotizing and granulomatous meningoencephalitis suggests that this predominantly
canine disease can afflict humans as well. Further research is necessary to determine pathogenesis in both humans and canines. This case demonstrates that the use of glucocorticoids
for the treatment of necrotizing granulomatous meningoencephalitis, as in canines, may slow
progression of the disease. Our patient remained clinically stable with no evidence of radiologic progression for 4 years after initial steroid treatment. Further research is necessary to
determine ideal treatment protocols and to further evaluate the use of immunomodulatory
therapy in this disease entity.
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Fig. 1. MRI of the brain with and without gadolinium at presentation. a–c T1 post contrast images demon-

strating nodular enhancement in the left frontal cortex (a), left parietal cortex (b), and right occipital cortex
(c). d T2 imaging with vasogenic edema in the left frontal cortex with central hypointensity in the area of
enhancement. e, f T2 FLAIR with bilateral hyperintensities largely surrounding the area of enhancement.
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Fig. 2. MRI of the brain with and without gadolinium (4 years later). a–c T1 post contrast images demon-

strating new nodular enhancement in the left frontal cortex adjacent to biopsy site ( a), two small lesions
in the left parietal cortex (b), and new left anterior temporal cortex (c). d T2 imaging with vasogenic edema
in the left frontal cortex with central hypointensity in the area of biopsy. e, f T2 FLAIR wit bilateral hyperintensities in the areas of enhancement.

307

Case Rep Neurol 2018;10:302–308
DOI: 10.1159/000494079

308

© 2018 The Author(s). Published by S. Karger AG, Basel
www.karger.com/crn

Taddonio et al.: Human Chronic Necrotizing Granulomatous Meningoencephalitis

Table 1. Summary of laboratory and imaging results

Serum studies

CSF studies

Imaging/other

CBC

WBC – 16.27 k/μL
Hgb – 14.3 g/dL
Plt – 411 k/μL

Cell count

RBC – 15
lymphocyte – 1

CT of the chest,
abdomen and
pelvis

mild bullous emphysema, no primary
malignancy or metastases

HgbA1c

7.8%

Glucose

65 mg/dL

PET-CT

mild increased
asymmetric uptake
in right tonsil

ANA

negative

Protein

44 mg/dL

Nuclear medicine no evidence of skelbone scan
etal metastases

Complement

C3 – 161 mg/dL
(ref. 90–180)
C4 – 36 mg/dL
(ref. 10–140)

Cytology

benign

Mammogram

normal

SSA-SSB

negative

Myelin basic
protein

<2 mg/L
(ref. 0–4)

Colonoscopy

tubular adenoma

ANCA

negative

IgG Index

0.42
(ref. <0.66)

PPD

negative

ESR

17 mm/h
(ref. 0–20)

Oligoclonal bands

5 gamma-restricted bands
with serum correlate

EEG ×4

left frontotemporal
slowing without epileptiform discharges

CRP

7.58 ml/L
(ref. 0–5)

Culture anaerobic/aer- no growth
obic

ACE

6 U/L
(ref. 9–67)

Gram stain

no organisms or
PMNs

FTA-ABS

nonreactive

Fungal smear

no yeast or hyphae

Quantiferon

negative

Fungal culture

no growth

Cryptococcal
antigen

negative

Histoplasmosis/
negative
blastomycosis IgG
HIV negative

negative

Hepatitis panel

negative

SPEP

normal

